Skip to main content
. 2022 Oct 14;16:1012422. doi: 10.3389/fnana.2022.1012422

TABLE 2.

Effects of naringin administration on MDA, NO, and GSH levels in hippocampal and cerebellar homogenates.

Hippocampus

C N AlCl3 AlCl3 + N P-value
MDA (nmol/g) 10.1 ± 1.58 9.5 ± 1.25# 18.8 ± 2.1* 15.2 ± 2.3$ P < 0.001**
GSH (μmol/g) 1.65 ± 0.35 1.79 ± 0.48# 0.84 ± 0.12* 1.11 ± 0.21$ P < 0.001**
NO (μmol/g) 1.31 ± 0.47 1.25 ± 0.38# 2.37 ± 0.58* 1.98 ± 0.88$ P = 0.002**

Cerebellum

MDA (nmol/g) 15.5 ± 6.18 16.1 ± 2.48# 29.3 ± 6.85* 16.1 ± 2.48$ P = 0.004**
GSH (μmol/g) 2.14 ± 0.38 1.97 ± 0.26 1.15 ± 0.58 1.97 ± 0.26 P = 0.01
NO (μmol/g) 1.97 ± 0.77 2.15 ± 0.81# 3.41 ± 0.78* 2.15 ± 0.81$ P = 0.001**

n = 6 in each group. Data were prescribed as mean ± SD.

**Indicates significance among the studied groups indicated by ANOVA test. The intergroup variation was conducted by Games-Howell post-hoc test.

*Significance compared with C group.

#Significance compared with AlCl3.

$Significance compared with AlCl3.